Press releases

25
Mar 2015
20:30 E.S.T.

Cellectis Prices Initial Public Offering of American Depositary Shares

Read more
4
Mar 2015
21:30 E.S.T.

Cellectis: 2014 financial results

Read more
17
Feb 2015
21:30 E.S.T.

Cellectis SA Shareholders General Meeting of February 16, 2015

Read more
13
Jan 2015
21:30 E.S.T.

Cellectis and The Ohio State University, Through the Ohio State Innovation Foundation, Enter Into Licensing Agreement for Chimeric Antigen Receptor Technology Targeting Multiple Myeloma

Read more
8
Jan 2015
21:30 E.S.T.

Cellectis Plans to Conduct Registered Initial Public Offering in the U.S.

Read more
6
Jan 2015
21:30 E.S.T.

Cellectis announces the issuance by the USPTO of a patent covering a seminal nuclease-based “gene editing” method

Read more
18
Dec 2014
21:30 E.S.T.

Cellectis Plant Sciences and Two Blades Foundation Announce the Execution of a Cross-License Agreement on TAL Effector Nuclease Technologies

Read more
24
Nov 2014
21:30 E.S.T.

Cellectis Announces Upcoming Presentations at the 56th Annual Meeting of the American Society of Hematology (ASH)

Read more
12
Nov 2014
21:30 E.S.T.

Cellectis received proceeds of €13 Million through the exercise of warrants

Read more
4
Nov 2014
21:30 E.S.T.

TALENTM technology: Grant of EP 2 510 096 by the European Patent Office

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US